On July 17, the "Two Bombs, One Satellite" Spirit Chinese Youth Talent Forum and the "Wise Minds Gather at the Three River Source" Talent Project Matchmaking Conference for New Qinghai were grandly held in Xining, Qinghai. The conference was hosted by Cao Jun, Standing Committee Member of the Qinghai Provincial Committee and Director of the Organization Department. Wu Xiaojun, Secretary of the Provincial Committee and Chairman of the Standing Committee of the Provincial People's Congress, delivered a keynote address. Relevant central leaders attended and delivered speeches, and multiple academicians engaged in on-site exchanges. Academicians, experts, and leaders from government and industry gathered at this plateau summit to carry forward the red legacy of scientific research and national service embodied in the "Two Bombs, One Satellite" spirit, pooling national talent resources and scientific innovation momentum to empower Qinghai's high-quality development. Professor Shi Yuanyuan,Chairman of the Cell Valley Group, was invited to attend this prestigious event and completed the signing of a major strategic cooperation project.

      A centralized signing ceremony for major projects was held at the main venue of the conference opening. Witnessed by central leaders, Qinghai Provincial Party Secretary Wu Xiaojun, Governor Luo Dongchuan, attending academicians, and provincial and municipal leaders, Professor Shi Yuanyuan, Chairman of the Cell Valley Group, and Xu Cuntao, Member of the Standing Committee of the Party Committee of Qinghai University and Party Secretary of Qinghai University Affiliated Hospital, formally signed the agreement on behalf of both parties. The strategic cooperation agreement covers the hospital's cell therapy center enhancement project and the joint establishment of the Qinghai Provincial Public Service Platform for Cell Therapy.

This signing marks the official entry of Shenzhen Cell Valley into Qinghai and its strategic deployment in the Northwest medical science and innovation sector. Going forward, the Group will fully leverage its core strengths in cell therapy clinical translation, frontier technology R&D, professional talent cultivation, and full-chain industrial system development. It will deeply integrate with the high-quality clinical platform resources of Qinghai University Affiliated Hospital, focusing on key areas including precision diagnosis and treatment of plateau-specific diseases, clinical application of cell technologies, and joint cultivation of medical education talent. This collaboration will address regional gaps in high-end biopharmaceutical development, solidly support the construction of "Healthy Qinghai," and effectively promote the interconnection and shared utilization of high-quality medical resources between the eastern and western regions.

Building on this new starting point and forging ahead on a new journey, Shenzhen Cell Valley will continue to uphold the self-reliant and determined spirit of the "Two Bombs, One Satellite" legacy, taking root in Qinghai and deepening its commitment to the medical science and innovation track. By empowering the plateau's healthcare services with core frontier biotechnologies, the company will continuously support the innovative development of the biomedical industry in the western region, shoulder the responsibility of safeguarding public health with the strength of Greater Bay Area scientific innovation, and contribute solid industrial strength.